Loading clinical trials...
Loading clinical trials...
Sitagliptin Treatment in Patients With Type 2 Diabetes Mellitus After Kidney Transplant
Conditions
Interventions
Administration of sitagliptin
Locations
1
United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Start Date
April 1, 2007
Primary Completion Date
January 1, 2011
Completion Date
January 1, 2011
Last Updated
April 7, 2026
NCT05753930
NCT07232537
NCT06815081
NCT04128189
NCT06003153
NCT06278207
Lead Sponsor
University of Oklahoma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions